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Abstract Survival in Duchenne muscular dystrophy
(DMD) has increased in recent years due to iterative
improvements in care. We describe the results of the
CARE-NMD survey of care practices for adults with DMD
in the UK in light of international consensus care guide-
lines. We also compare the UK experience of adult care
with the care available to pediatric patients and adults in
other European countries (Germany, Denmark, Bulgaria,
Czech Republic, Hungary, and Poland). UK adults expe-
rience less comprehensive care compared to children in
their access to specialized clinics, frequency of cardiac and
respiratory assessments, and access to professional phys-
iotherapy. Access to the latter is especially poor when
compared to other European adult cohorts. Although the
total number of nights in hospital (planned and unplanned
admissions) is lower among UK adults than elsewhere in
Western Europe, social inclusion lags behind other Wes-
tern European countries. We observe that attendance at
specialized clinic is associated with more frequent cardiac
and respiratory assessments among adults, in line with
international best practice. Attendance at such clinics in the
UK, though comparable to other countries, is still far from
universal. With an increasing adult population living with
DMD, and cardiac and respiratory failure the leading
causes of death in this population, we suggest the need for
an urgent improvement in adult access to specialized
clinics and to consistent, comprehensive best practice care.
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Introduction
Duchenne muscular dystrophy (DMD) is a severe neuro-
muscular disease affecting one in 3,600–6,000 live male
births [1, 2], characterized by progressive muscle weakness
which causes loss of ambulation by the early teenage years.
Cardiac and respiratory complications are seen, especially
with disease progression, and if untreated DMD typically
leads to death in the late teens [3]. Although currently
incurable, the natural history of DMD has been improved
by targeted interventions addressing known disease com-
plications. Internationally generated and accepted consen-
sus care guidelines for DMD have been published and have
achieved NICE process accreditation in the UK [3–5].
Multidisciplinary care, particularly the initiation of corti-
costeroids and assisted ventilation supported by regular
cardiac and respiratory monitoring, has led to increasing
numbers of patients living into adulthood in recent years
(Bladen, manuscript in preparation) [6–8]. This adult
population requires continued specialist multidisciplinary
care. Cardiac and respiratory complications are the primary
cause of death in DMD, and regular monitoring of heart
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and lung function is an important pillar of best practice
care for adults [4]. It is known that transition from child-
hood to adulthood poses a range of challenges in DMD and
other chronic conditions with complex healthcare needs,
relating both to the transfer of medical care and to the
wider process of societal transition and integration [9–12].
Reports suggest that care for DMD across all age groups
varies significantly both within and between countries,
including in the UK [13]. However, quantitative data has so
far been lacking, particularly for the adult population.
Within the 3-year EU-funded CARE-NMD project [14],
we have been able to study the experience of care in DMD
in seven European countries (Kirschner, manuscript in
preparation). Given the progressive nature of the condition
and the increasing numbers of people with DMD living
into adulthood, it is timely to consider the extent to which
the care received by adults with DMD is in line with
international consensus recommendations. Using data col-
lected during the CARE-NMD patient survey of care
practices, this study investigates the care received by UK
adults and compares it to the recommended care guide-
lines, the care received by pediatric patients in the UK, and
the care received by the adult cohorts in other countries
surveyed.
Methods
The CARE-NMD project conducted a cross-sectional,
multi-center study surveying care practices and quality of
life in DMD in seven European countries: Bulgaria, the
Czech Republic, Denmark, Germany, Hungary, Poland,
and the United Kingdom (Kirschner, manuscript in prepa-
ration). The project collected self-report data via surveys of
patients/families with DMD and neuromuscular clinics
treating those with the condition.
This paper describes adult results from the two-part
patient and family questionnaire, which examined the care
received and quality of life experienced by those living
with DMD. The 42-question care survey captured socio-
demographic variables, as well as information about daily
life, functional abilities, disease progression, and medical
and social care received. The survey was designed by
project partners to determine the extent to which partici-
pants received the care outlined in the consensus care
recommendations. It was translated into the local language
by project partners in each country, and piloted on between
five and ten patients and their families in each country for
comprehensibility. Any adjustments were then reconciled
with the original English version before full distribution.
The quality of life section used existing validated health-
related quality of life (HRQoL) instruments. PedsQL
Generic and Neuromuscular modules, WHO-QOL BREF,
and SF-36 were chosen based on criteria including existing
validation in most project languages, availability of refer-
ence values for most participating countries, previous use
in studying DMD, and inclusivity of ages from 2 years to
adulthood. The range of instruments permitted the utiliza-
tion of age-appropriate HRQoL surveys for all participant
age groups: for those under 18 years, both patient- and
parent-report surveys were distributed1.
Combined questionnaire packs were distributed in each
country on behalf of the project via national DMD patient
registries, which form part of the TREAT-NMD Global
DMD Registries [15]. This ensured that age-appropriate
HRQoL surveys were sent while preserving respondent
anonymity, ensuring the CARE-NMD project team could
not identify any individual. Links to electronic question-
naires, hosted on SurveyMonkey, were distributed elec-
tronically where e-mail addresses were available; paper
versions were sent in other cases, or where no response or
opt-out was received electronically. Data collection took
place between September 2011 and April 2012, with paper
versions input into the SurveyMonkey questionnaire by the
CARE-NMD project leaders at University Medical Center
Freiburg. Data analysis was carried out in IBM SPSS and
Microsoft Excel.
Results
We present here the results on the care received by adults
with DMD in the UK in the wider context of the experience
of under-18s in the UK, and of adults in the other countries
surveyed. In particular, in these comparisons we have
mainly focused on Denmark and Germany due to compa-
rable cohorts, and similar characteristics as Western
European states with robust healthcare systems. Future
manuscripts will examine other data from the CARE-NMD
survey, including Eastern European countries, quality of
life, and child cohorts.
Demographics
1,062 valid responses were received from 1,677 surveys
distributed (63.3 % response rate). Both the proportion and
absolute number of adult responses varied considerably
between countries, and were lower in Eastern than Western
Europe (Table 1). 226 responses (21.3 %) were from UK
patients, with 42 (18.6 %) aged over 18. Although the
overall UK response rate was the lowest in Western Eur-
ope, the proportion of adults who responded in the UK
(18.6 %) was similar to Germany (18.3 %). UK responses
1 With the exception of the 2–4 year age group, where only the
parent report was distributed.
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made up 20.9 % of the adult responses, comparable to
Denmark (21.4 %).
The age distribution of the UK adult cohort was
weighted toward younger adults, with 35 (83.3 %) aged
under 27 (Table 2). This was similar to Germany (81.8 %),
though considerably different from Denmark where 44.2 %
were aged under 27, and more than one-third over 33 years
old. The age distribution of adults in Eastern Europe was
also significantly weighted toward younger adults, with the
majority in all countries except Poland aged 18–22.
With a mean age of 24.1 years, the UK adult cohort was
slightly younger than that across all countries (24.8 years).
All were non-ambulatory: mean UK loss of ambulation was
10.4 years, somewhat younger than the overall adult cohort
of 11.1 years. Average age at diagnosis was 4.6 years, the
lowest of the adult cohorts, and a little more than 6 months
younger than the mean.
None report having a job, with 25.6 % still in education
(secondary school, special needs school, vocational train-
ing, or university). Occupational status contrasted starkly
with Germany, where 49.4 % were in education and a
further 16.9 % were employed. The proportion of UK
adults in education was comparable to that of Denmark
(18.6 % in education), though a further 16.3 % were in
employment in that country. In the four Eastern European
countries2, although none of the 39 adults surveyed were in
employment, 17 (43.6 %) were in education (Fig 1a).
A similar pattern emerged with living arrangements,
where the proportion of UK adults living independently
(7.1 %) was lower and the proportion living at home
(92.9 %) higher than elsewhere in Western Europe. No
adults in the UK reported living with a partner. In Den-
mark, 60.5 % lived independently or with a partner and
34.9 % lived with their family, while in Germany these
figures were 13.0 and 76.6 %, respectively. In Eastern
European countries, all adults reported living at home
(Fig 1b). More than three times as many adults reported not
getting out of the house at all in a typical week in the UK
(28.6 %) than in Denmark (9.3 %).
Satisfaction and specialized clinic experience
UK adult satisfaction with care was lower than elsewhere in
Western Europe, while dissatisfaction is higher; three-quar-
ters of UK adults said they were ‘‘very’’ or ‘‘rather’’ satisfied
(Table 3). Adult satisfaction in the UK was also lower and
dissatisfaction higher than in the UK pediatric cohort (86.5
and 13.5 %, respectively). Satisfaction among German adults
was comparable to the UK pediatric cohort, while Danish
adults were overwhelmingly satisfied with their care.
International consensus DMD care guidelines recom-
mend multidisciplinary care managed by a disease expert,
with co-ordinated interventions from other specialities as
required. Such care, particularly during childhood, is often
delivered via specialized neuromuscular clinics. Indeed,
the loss of the pediatric family centric approach during
transition to adult clinics has been identified as a challenge
for young people with DMD [12]. UK families highly
value the continuity provided by a transition model
continuing their access to the same specialized team [16].
73.2 % of UK adults attend what they recognized as a
specialized clinic at least once annually, with 41.5 % of
these attending at least once every 6 months. Both figures
were considerably lower than the UK pediatric cohort
(96.6 % with 69.0 % attending every 6 months). At least
annual attendance was slightly higher than adult cohorts in
Germany (68.9 %) and Denmark (69.0 %), and signifi-
cantly higher than Eastern Europe (25.6 %). However, of
the three Western European countries, UK adults reported
the highest rate of complete non-attendance at a specialized
clinic (22 %), compared to 11.9 % in Denmark and 18.9 %
in Germany. Complete non-attendance in Eastern Europe
ranged between 85.7 % (Bulgaria) and 40 % (Hungary),
with a mean of 64.1 % (Fig 2a).
Table 1 Adult respondents to








UK 421 226 (53.7) 42 18.6 20.9
Germany 545 420 (77.1) 77 18.3 38.3
Denmark 131 88 (67.2) 43 48.9 21.4
Western Europe 1,097 734 (66.9) 162 22.1 80.6
Bulgaria 73 40 (54.8) 7 17.5 3.48
Hungary 70 57 (81.4) 5 8.8 2.49
Poland 246 142 (57.7) 16 11.3 7.96
Czech Republic 191 89 (46.6) 11 12.4 5.47
Eastern Europe 580 328 (56.6) 39 11.9 19.4
Overall 1,677 1,062 (63.3) 201 18.9 100
2 Bulgaria, the Czech Republic, Hungary, and Poland.
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Adults who attended a specialized clinic at least annually
were more satisfied with their care than those who did not
(Fig 2b). Of eight UK adults who claimed to be ‘‘very
satisfied’’, all attended a specialized clinic annually and
seven (87.5 %) attended at least every 6 months. Among
those who were dissatisfied, two attended a specialized
clinic every 6 months while four attended less than
annually; three of the latter never attended, including the
only individual who was ‘‘not satisfied at all’’. A link
between specialized attendance and satisfaction was also
found in the other countries and in the UK pediatric cohort.
All seven UK adults who never attended a specialized clinic
and who also provided a reason reported ‘‘distance’’ for
their non-attendance. This reason was not reported by any
of the four pediatric patients who did not attend a center.
Staff at a specialist center should not only be familiar
with best practice care, but also provide appropriate infor-
mation to DMD patients about their condition and treatment
options. We asked whether respondents felt the information
they received was sufficient across several important areas
of care for adults: the course of the disease and main
problems that may arise; the use of steroids; breathing
problems; and cardiac problems. Responses were compared
across three groups: adults not seen at specialized clinics
annually, and both adults and children seen annually.
UK adults who did not attend a specialized clinic annu-
ally reported considerably lower levels of sufficient infor-
mation provision across all four areas than adults who did,
with a substantial difference observed about information on
steroids, breathing problems, and cardiac problems. In some
cases, the proportion of those receiving sufficient informa-
tion among non-attendees was less than half of those seen at
a specialized clinic annually (Table 4). The proportion of
adults who were provided with information was lower
among specialized clinic attendees than non-attendees.
Non-provision of information varied by topic, but was more
than 12 times (general information and complications), 9
times (breathing problems), 6 times (cardiac problems), and
3 times (steroids) lower among those seen at a specialized
clinic than among those who were not.
Although both adults and children who were treated at a
specialized clinic reported similar levels of sufficient
knowledge about the disease overall, there were differences
in relation to steroids, breathing problems, and cardiac
problems. Sufficient information on steroid treatment was
lower and those without information were higher among
adults.
Fig. 1 Demographics of adult cohort: a occupational status of adults
with DMD by country, b living arrangements of adults with DMD by
country
Table 2 Age distribution of adult respondents to CARE-NMD Sur-
vey by country
Country 18–22 23–27 28–32 33?
UK 21 14 4 3
Germany 46 17 9 5
Denmark 10 9 9 15
Western Europe 77 40 22 23
Bulgaria 5 1 1 0
Hungary 4 1 0 0
Poland 7 5 3 1
Czech Republic 10 1 0 0
Eastern Europe 26 8 4 1
Overall 103 48 26 24
Table 3 Overall satisfaction with care (UK adults, UK children,











Very satisfied 8 (19.5 %) 49 (28.8 %) 16 (22.5 %) 21 (51.2 %)
Rather satisfied 23 (56.1 %) 98 (57.6 %) 46 (64.8 %) 18 (43.9 %)
Satisfied 31 (75.6 %) 147 (86.5 %) 62 (87.3 %) 39 (95.1 %)
Rather
dissatisfied
9 (22.0 %) 20 (10.9 %) 8 (11.3 %) 2 (4.9 %)
Not satisfied
at all
1 (2.4 %) 3 (1.6 %) 1 (1.4 %) 0 (0 %)
Dissatisfied 10 (24.4 %) 23 (13.5 %) 9 (12.7 %) 2 (4.9 %)
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Hospital admissions and care
Hospital admissions
172 adults provided complete information about the cause
and overall duration of hospital admissions in the 2 years
prior to the survey (137 from Western Europe, 34 from
Eastern Europe). 40 adults in the UK provided this infor-
mation with 15 (40 %) spending at least one night in
hospital. On average, attendees spent 12 nights in hospital
for a total of 184 overnights, of which the majority
(57.6 %) were unplanned admissions. More than three-
quarters (77.4 %) of these unplanned admissions were due
to acute respiratory problems such as chest infection.
Planned admissions in the UK were mainly for regular
checkups (46.2 %) and planned surgery (48.7 %).
Fewer UK adults were admitted to hospital than in other
Western European countries, and collectively they spent a
lower overall number of nights as inpatients (Fig 3a). In
Germany, 52.5 % of adults were admitted, recording 576
overnights (averaging 18 nights per patient admitted).
70.3 % of adults in Denmark were admitted: while the
average number of nights per patient was the same as the
UK (12), the overall nights recorded (304) was, therefore,
considerably more.
A similar proportion of German admissions were unplan-
ned (61.3 %) as in the UK, while in Denmark the ratio of
admissions was reversed with the majority (57.2 %) being
planned. In Germany, the proportion of unplanned admissions
attributed to respiratory crises was similar (78.2 %) to the UK,
while in Denmark it was considerably lower (42.3 %)
(Fig 3b). The Danish cohort also had a much lower proportion
(25.3 %) of nights in hospital attributed to regular checkups
than the UK (46.2 %) and Germany (67.3 %) (Fig 3c).
Seven of ten UK adults with unplanned hospitalizations
reported respiratory problems as their sole cause of
admission, all of whom were mechanically ventilated.
There were no clear patterns to this group: most attended a
specialized clinic, received at least annual assessments of
lung function, and were informed of breathing complica-
tions. There likewise appeared to be no clear association
between this cause of admission and age in the UK, nor any
other country surveyed.
Fig. 2 Neuromuscular clinic experience a attendance at specialized
clinic. b Satisfaction with care among adults who attend a specialized
clinic annually and those who do not
Table 4 Provision of information about important aspects of DMD care to different groups in the UK






Respondents rating the provision of information as ‘‘sufficient’’ in each area
The course of the disease and the main problems that may arise 44.4 67.9 70.7
Treatment with steroids in DMD 25.0 58.6 78.9
Breathing problems in the course of DMD 44.4 85.2 46.4
Cardiac problems in DMD 33.3 69.0 56.6
Respondents who responded ‘‘no, not at all’’ in relation to information being provided on
The course of the disease and the main problems that may arise 44.4 3.6 4.8
Treatment with steroids in DMD 62.5 20.7 2.4
Breathing problems in the course of DMD 33.3 3.7 22.9
Cardiac problems in DMD 22.2 3.4 13.3
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Cardiovascular care
Information on the cardiac complications of DMD was
provided to 90.2 % of UK adults, but almost one-third felt
that this was insufficient and a further 7.3 % received no
information. A very similar pattern was reported by Danish
and German adults. ‘‘Sufficient’’ information was lower,
and ‘‘insufficient’’ or ‘‘no’’ information higher, in Eastern
Europe (Table 5). Provision of cardiac information to UK
children aged 10–17 was similar to adults at 90.3 %, but a
slightly higher proportion (65.6 %) rated this information
‘‘sufficient’’. Of those aged under 10, 83.3 % received
cardiac information with only 44.9 % rating it as sufficient
(Fig 4a).
69.0 % of adults in the UK received at least annual
echocardiograms, compared to 79.7 % in Germany and
65.1 % in Denmark. In the UK, only 9.5 % were assessed
at least every 6 months, lower than in Germany (33.8 %)
or Denmark (16.3 %). The proportion of adults receiving at
least annual cardiac assessment was also notably lower
than that of UK children aged 10–17 (86.3 %) (Fig 4b).
52.4 % of UK adults reported a diagnosis of cardio-
myopathy, similar to Germany (50.5 %) and Denmark
(41.9 %). There appears to be no relationship between
diagnosis of cardiomyopathy and specialist clinic atten-
dance. Almost two-thirds (65.9 %) of UK adults received
medications for cardiomyopathy, of which 22.2 % did so
prophylactically. Among UK adults not diagnosed with
cardiomyopathy, almost half were treated prophylactically
for cardiac failure, a much higher proportion than any other
country surveyed: only 25 % were so treated in Germany,
and none in Denmark (Fig 4c). A similar trend was evident
in the UK pediatric cohort aged 10–17.
Respiratory care
89.7 % of UK adults received information on respiratory
complications, with one-fifth regarding this as insufficient
and a further 10.3 % not receiving any information. Ger-
man adults experienced similar proportions of ‘‘sufficient’’
and ‘‘insufficient’’ information, while Danish adults report
higher rates of sufficient information (Table 6). A clear
trend was that more adults (89.7 %) received information
Fig. 3 Hospital admissions of adult cohorts in Western Europe:
a overall number of planned and unplanned nights spent in hospital by
country, b proportion of unplanned nights spent in hospital by cause,
c proportion of planned nights spent in hospital by cause
Table 5 Provision of
information to adults about
cardiac complications by
country
Country (valid responses/n) Provision of information about cardiac complications
Sufficient Insufficient No information Do not remember
UK (41/42) 24 (58.5 %) 13 (31.7 %) 3 (7.3 %) 1 (2.4 %)
Germany (73/77) 51 (69.9 %) 16 (21.9 %) 3 (4.1 %) 3 (4.1 %)
Denmark (43/43) 25 (58.1 %) 13 (30.2 %) 4 (9.3 %) 1 (2.3 %)
Eastern European countries (39/42) 17 (47.2 %) 14 (38.9 %) 5 (13.9 %) 0 (0.0 %)
634 J Neurol (2015) 262:629–641
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on respiratory issues than those aged 10–17 (84.0 %) and
those under 10 (67.9 %). A more dramatic difference was
the proportion who received ‘‘sufficient’’ information:
71.8 % among adults, 51.5 % of those aged 10–17, and
31.3 % among under-10s (Fig 5a).
Across all countries a similar proportion of adults had at
least annual lung function assessment: 69.0 % (UK),
75.7 % (Germany), and 67.4 % (Denmark). The UK and
Germany assessed a greater proportion of these at least
every 6 months (45.2 and 39.2 %, respectively) compared
to Denmark (7.0 %). With 87.4 % of UK children aged
10–17 reporting at least annual checks, the lower rate of
such tests among adults parallels the lower rate of annual
cardiac assessment for these two groups (Fig 5b).
Mechanical ventilation was used by 69 % of UK adults,
with 47.6 % using intermittent non-invasive ventilation
(NIV), 16.7 % using continuous NIV, and 4.8 % continu-
ously ventilated via a tracheostomy. Ventilation practice
differed markedly between countries: in the UK, the
overwhelming majority (93.1 %) of adults with mechanical
ventilation used NIV, while continuous NIV use was also
the highest of all countries surveyed. In Germany 88.4 %
of ventilated adults used NIV, while in Denmark it was
fewer than one in four (23.7 %) with most instead having a
tracheostomy. Eastern Europe recorded low rates of ven-
tilation (Fig 5c).
In all countries, invasive ventilation was strongly linked
to increased age. The proportion of adults using NIV fell
from 89.6 % aged 18–22 to 26.1 % of those aged 33 or
older. However, these figures were affected by country, as
of the 17 adults aged 33 or older with invasive ventilation,
14 (82.4 %) were in Denmark.
Physiotherapy
97.6 % of UK adults received information on preventing
scoliosis and contractures, although 14.6 % felt it was
insufficient. This is similar to Germany (94.5 and 12.3 %,
respectively) while Danish adults all reported being
informed and fewer regarded the information they received
as insufficient (100 % and 9.3 %). Eastern European adults
were less well informed (81.6 and 42.1 %) (Table 7).
The proportion of adults who have ever received
instruction on home stretching was strikingly similar across
countries (84–90 %), but that which believe this to be
Fig. 4 Cardiac care: a quality of information provided to different
age groups in the UK on cardiac risks, b frequency of echocardiogram
received by UK adults, UK children, and adults in Germany and
Denmark, c diagnosis and prophylactic treatment of cardiomyopathy
among adults by country
Table 6 Provision of
information to adults about
respiratory complications by
country
Country (valid responses/n) Provision of information about respiratory complications
Sufficient Insufficient No information Do not remember
UK (39/42) 28 (71.8 %) 7 (17.9 %) 4 (10.3 %) 0 (0.0 %)
Germany (74/77) 52 (70.3 %) 14 (18.9 %) 5 (6.8 %) 3 (4.1 %)
Denmark (41/43) 35 (85.4 %) 37 (19.5 %) 1 (2.4 %) 1 (2.4 %)
Eastern European countries (36/42) 18 (50 %) 12 (33.3 %) 6 (16.7 %) 0 (0.0 %)
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sufficient varied considerably. Furthermore, notably fewer
UK adults regarded information as ‘‘sufficient’’ (69.0 %)
than children (82.7 %) (Fig 6a). Access to professional
physiotherapy in the UK was very low: few adults (21.4 %)
received it at all and only 4.8 % received more than 60 min
weekly; the majority (64.3 %) used to receive physiother-
apy but no longer receive it (Fig 6b). In contrast profes-
sional physiotherapy was received by 93.2 % of German,
87.8 % of Danish, and 51.3 % of Eastern European adults
(74.3, 36.6, and 38.5 % over an hour per week, respec-
tively). While UK children had considerably better access
to professional physiotherapy than adults (55 %, with
18.1 % at least 60 min weekly), it was still far less than the
pediatric cohorts in Germany, Denmark, and Eastern Eur-
ope (91.8, 93.3, and 73.5 % overall access, with 55.8, 53.5,
and 53.8 % weekly, respectively).
At least annual assessment rates for scoliosis (inspection
or spinal radiograph) among adults varied significantly
(Fig 6c): 29.7 % (UK), 39.4 % (Germany), and 4.9 %
(Denmark), while complete non-assessment was experi-
enced by 37.8, 26.8, and 53.7 % of adults, respectively.
Again, scoliosis assessment for UK adults was lower than
for UK children. In the UK, 27.5 % of adults received at
least annual assessment of functional abilities, and 45 %
reported total non-assessment (Fig 6d). Annual adult
functional assessment was lower in the UK than Germany
(50.7 %), though somewhat higher than Denmark (20.9 %)
and Eastern Europe (21.2 %). It was also in stark contrast
to UK children, 85.5 % of whom were assessed annually
and only 5.2 % not assessed at all.
Patterns of multidisciplinary care
These data demonstrated diverse care practices for adults
with DMD in the UK. We sought to understand the rela-
tionship between different aspects of care, to determine
whether certain patients benefited from comprehensive
multidisciplinary care. The largest single group of UK adults
were the 14 (33 %) receiving at least 6 monthly respiratory
and at least annual cardiac assessments. However, we noted
a sizeable proportion of UK adults receive less than annual
respiratory and cardiac assessments (31 % in each case), and
investigated links between these two factors.
Fig. 5 Respiratory care: a quality of information provided to
different age groups in the UK on respiratory risks, b frequency of
lung function assessment received by UK adults, UK children, and
adults in Germany and Denmark, c differences in ventilation practice
among adults by country
Table 7 Provision of
information about scoliosis and
contractures by country
Country (valid responses/n) Provision of information about scoliosis and contractures
Sufficient Insufficient No information Do not remember
UK (41/42) 34 (82.9 %) 6 (14.6 %) 1 (2.4 %) 0 (0.0 %)
Germany (73/77) 60 (82.2 %) 9 (12.3 %) 4 (5.5 %) 0 (0.0 %)
Denmark (43/43) 39 (90.7 %) 4 (9.3 %) 0 (0.0 %) 0 (0.0 %)
Eastern European countries (38/42) 16 (42.1 %) 15 (39.5 %) 6 (15.8 %) 1 (2.6 %)
636 J Neurol (2015) 262:629–641
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There was considerable overlap between those who
received both cardiac and respiratory assessments at least
annually (24 individuals, 57.1 %), while eight individuals
(19.0 %) received neither (Pearson’s Chi square,
p \ 0.005). Similar correlations were observed in Germany
(71.6 % both and 16.2 % neither, p \ 0.001) and Denmark
(51.2 % both and 18.6 % neither, p \ 0.05). Across all
Western European countries, these data were significant to
p \ 0.001 (Fig 7a).
Investigating the relationship between specialized clinic
attendance and annual assessments of both respiratory and
cardiac function revealed that the largest group was those
who were seen at a specialized clinic (20 individuals,
48.8 %). Conversely, only three adults who did not attend a
specialized clinic received such frequent assessments.
However, of 18 UK adults not seen at least annually for
both assessments, a slight majority (10, 55.6 %) did attend
a specialized clinic (p \ 0.05).
A similar pattern emerged in Germany and Denmark,
and is significant in both. Across Western Europe, this
pattern is significant to p \ 0.001. In Eastern Europe, a
similar pattern is observed (p \ 0.05). The single largest
group in Western Europe were 82 individuals (52.2 %) both
seen at a specialized clinic and receiving annual cardiac and
respiratory assessments, while in Eastern Europe it is 27
adults (69.2 %) who are neither seen at a specialized clinic
nor receive both annual assessments (Fig 7b).
Discussion
To our knowledge, we have conducted the largest survey of
DMD patients to date, and this study highlights consider-
able differences between the care received by adults and
children in the UK. It also reveals distinctive care practices
and differing levels of societal integration of adults with
DMD between the UK and other European countries.
We are mindful of limitations including incomplete
coverage of the DMD population and the study design.
While the CARE-NMD was unprecedented in size and had
a good response rate (53.7–77.1 % in Western Europe), the
scarcity and life-limiting nature of DMD resulted in rela-
tively few adult respondents overall. Once stratified by
country and other attributes, this precluded advanced sta-
tistical analyses, especially in Eastern Europe. Further-
more, questionnaire distribution via opt-in patient registries
will likely have resulted in selection bias: registries tend to
attract patients who are most engaged with the DMD
community, and who are aware of and more inclined to
campaign for best practice care. However, with short-
comings in treatment apparent even for this better-
informed population, we feel this does not detract from our
findings.
The study design also precluded the analysis of care of
those who have died (unlike a retrospective case review or
audit) which might identify patterns of care leading to
specific clinical outcomes. We did not ask respondents to
name the clinic(s) they attended, as we felt this would have
reduced participation due to the possibility of individual
identification. However, this also prevents us from identi-
fying specific examples of good or poor practice. Finally,
self-report questionnaires may not accurately reflect clinic
provision, and cannot account for non-attendance of
patients registered with a center that otherwise provides
comprehensive care. In spite of these limitations, we
believe that this study provides a valuable insight into the
current care received by adults with DMD in the UK.
Care for adults in the UK is considerably less compre-
hensive than for children, and fewer adults attend spe-
cialized neuromuscular clinics. Adults are also less likely
to be satisfied with their care and considerably less likely to
have their functional abilities assessed or to receive pro-
fessional physiotherapy than children. A large proportion
report that they formerly had access to professional phys-
iotherapy, supporting previous findings that such access is
especially poor among adults with chronic conditions in the
UK [13, 17, 18], and that there is a particular problem at
transition from childhood to adulthood. This conclusion is
reinforced by other results from this survey. Most notably
adults are less likely than those aged 10–17 to receive at
least annual echocardiograms and lung function checks as
recommended in the care guidelines to all patients aged
over 10 years. In spite of an increased need, best practice
care provision thus actually declines as these men reach
adulthood. This lends weight to previous studies which
found that transition, and especially transfer to adult ser-
vices, is a critical point when access to comprehensive care
is lost in DMD [12, 19, 20] and other chronic conditions
[21].
Compared to elsewhere in Europe, care for adults with
DMD in the UK is inconsistent. Although annual and
6 monthly attendance of adults at specialized clinics in the
UK is higher than elsewhere, the proportion of adults who
do not attend one at all is also the highest of the Western
European countries surveyed (22 %). The UK also has a
very low rate of social inclusion, with the highest propor-
tion of adults living with their family in Western Europe
and the lowest proportion living independently and par-
ticipating in employment or education. These data support
previous findings, both on the UK experience [16, 19] and
how it compares to independent living in Denmark [11].
The UK has by far the lowest access to adult physiotherapy
of any country surveyed, most likely because long-term
adult physiotherapy is not commonly funded through the
National Health Service. It also reflects a very low rate of
access to professional physiotherapy in the UK generally,
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with the pediatric cohort also the lowest of all countries.
For adults, maintaining upper extremity function helps to
preserve functional abilities which enable independence
(such as wheelchair and assistive device use), which
alongside preventing painful contractures and stiffness can
improve quality of life [8, 22].
In other areas, UK care practices for adults with DMD
are more positive. The rate of instruction in home
stretching is comparable to Germany and Denmark, which
may offset the lack of professional physiotherapy.
Although a sizable minority of adults does not receive the
recommended frequency of cardiac and respiratory checks,
these results are broadly similar to elsewhere in Western
Europe and are considerably better than in Eastern Europe.
bFig. 6 Physical assessment and physiotherapy: a instruction received
on home stretching, b frequency of professional physiotherapy,
c frequency of spinal assessment, d frequency of functional
assessment
Fig. 7 Patterns of multidisciplinary care: a relationship between
annual cardiac and annual respiratory assessments among adults by
country, b relationship between attendance at a specialized clinic and
annual assessments among adults by country
638 J Neurol (2015) 262:629–641
123
The UK also has the highest rate of prophylactic admin-
istration of cardiac medication among adults (42.9 %) and
children aged 10–17 (14.9 %) of all countries surveyed,
approximately double that in Germany and over three times
that in Denmark.
UK adults also spent fewer nights in hospital overall and
per patient, for both planned and unplanned admissions,
than adults elsewhere in Western Europe. The single
largest cause of admissions was unplanned respiratory
crises, which accounted for more than three-quarters of
unplanned admissions in the UK and Germany. In spite of
their advanced age, the proportion of Danish unplanned
nights in hospital due to respiratory crises is very low and
considerably lower than in the UK. Reducing unplanned
hospital admissions has been the subject of significant
research, as they are problematic for the individual and
costly to the health system [23, 24]. Previous research has
identified problems associated with unplanned admissions
in neuromuscular conditions [25], and a recent audit sug-
gested that up to a third may be preventable [26, 27]. These
results suggest that although the UK records a low absolute
number of nights spent in hospital for adults with DMD,
more could be done to reduce unplanned respiratory
admissions, particularly as the study design may also
underestimate the number of nights attributable to this
cause as it does not record those experienced by patients
who died following such admissions.
It is striking that almost all ventilated UK adults use
non-invasive NIV, while in Denmark most have a trache-
ostomy, likely due to long-standing differences in cultural
attitudes and medical practices toward invasive ventilation.
The UK has the highest rate of continuous NIV of any
country, while Denmark appears to switch from intermit-
tent NIV to invasive ventilation. However, these data also
show that invasive ventilation is strongly linked to the age
of the respondent, and as the Danish cohort includes many
more older men (48.8 % are over 30 vs. 9.5 % in the UK,
with more than 80 % of those aged over 33 being Danish),
it is not possible to say with certainty whether these dif-
ferences are solely due to cultural or healthcare system
preference. It is also notable that no clear pattern emerged
between UK unplanned admissions and respiratory care
practices, nor did age appear to be the determining factor in
unplanned adult admissions in the UK or elsewhere in
Western Europe.
We demonstrate a statistically significant link between
frequency of cardiac and respiratory assessments, and
between regular attendance at a specialized center and
more frequent assessment. Given significant mortality
associated with cardiac and respiratory failure in this
population, and the importance of heightened vigilance for
these complications, best practice care for adults with
DMD may be best delivered in a specialized
neuromuscular clinic. This supports findings from cystic
fibrosis (CF) and other life-limiting chronic conditions [28,
29]. With most adults who provide a reason for non-
attendance at a specialized clinic citing the distance they
would need to travel, we suggest that the difficulties
associated with traveling as a wheelchair and ventilator-
dependent adult may lie behind this non-attendance.
We also found that adult attendees of specialized clinics
are more likely to be satisfied with their care than non-
attendees, a pattern also observed across Europe. Attendees
of specialized clinics are also better informed of the disease
and its complications. This is unsurprising, as a core
rationale for such centers is to concentrate and develop
specialist expertise and provide tailored information to
patients [30]. Medical professionals outside these centers
may not see sufficient patients to be fully aware of best
practice care, or may be less inclined to provide this
information to patients than staff at a specialized clinic.
Those aged 10–17 are more likely to receive sufficient
information about cardiac and respiratory risks than the
under-10s, probably due to the increased need for respira-
tory and cardiac intervention from the second decade. The
low proportion of adults receiving information on steroid
treatment likely reflects its relatively recent introduction as
part of best practice care [3], a conclusion supported by a
disparity in the mean age of those attending a specialist
center who did not receive information on steroids
(27.2 years) and those who did (21.6 years).
The data we present expands upon and quantifies
previous studies which have noted the paucity of best
practice adult care provision for DMD and the difficulties
experienced at transition. It emphasizes the need for a
comprehensive, co-ordinated programme of multidisci-
plinary care and social support for the growing number of
adults living with DMD in the UK. Until recently, there
has been no systematic commissioning for adult neuro-
muscular care in the UK, though this is now part of the
specialized commissioning remit [31]. With nearly a third
of UK adults not receiving the recommended cardiac and
respiratory checks, there is significant room to improve
care for this population, and some areas require consid-
erable attention to ensure that adults with DMD in the UK
receive care in line with current best practice
recommendations.
Acknowledgments CARE-NMD was co-funded by the EU Exec-
utive Agency for Health and Consumers (20091205). We gratefully
acknowledge the work of all members of the CARE-NMD team who
are not co-authors to this paper but contributed significantly to the
project: Velina Guergueltcheva, Violeta Antonova, and Ivailo Tour-
nev (Bulgaria); Petr Brabec, Lenka Mra´zova´, Lenka Pavlovska´, Jana
Strenkova, and Petr Vondra´cˇek (Czech Republic); Birgit Steffensen,
Annette Mahoney, and Jes Rahbek (Denmark); Marı´a de los Angeles
Beytı´a, Sam Doerken, and Adrian Tassoni (Germany); Ma´rta Garami,
Veronika Karcagi, and A´gnes Herczegfalvi (Hungary); Anna
J Neurol (2015) 262:629–641 639
123
Kaminska, Anna Kostera-Pruszczyk, Anna Lusakowska, and Anna
Wasylyszyn (Poland). In addition, we are grateful for the invaluable
assistance of all CARE-NMD collaborating partners, a full list of
whom is available on the CARE-NMD project website [14].
We are indebted to the logistical support of the national DMD
registries in the seven participating countries. In the UK, we partic-
ularly acknowledge the contributions of Action Duchenne and the
Muscular Dystrophy Campaign to the CARE-NMD project. Finally,
we are very grateful to all the participants, both patients and their
families, who took the time to respond to the questionnaire.
Conflicts of interest The authors declare that they have no conflict
of interest.
Ethical standards The study was approved by the ethics committee
at the University Medical Center Freiburg, and as a condition of
distribution via national DMD patient registries was also approved by
the TREAT-NMD Global Database Oversight Committee. Respon-
dents gave their informed consent prior to completing the survey.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Emery AE (1991) Population frequencies of inherited neuro-
muscular diseases—a world survey. Neuromuscul Disord
1(1):19–29
2. Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R,
Gastier-Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil
C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N,
Chandrasekar R, Weiss RB (2012) Evidence-based path to
newborn screening for Duchenne muscular dystrophy. Ann
Neurol 71(3):304–313. doi:10.1002/ana.23528
3. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe
L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro
F, Tomezsko J, Constantin C (2010) Diagnosis and management
of Duchenne muscular dystrophy, part 1: diagnosis, and phar-
macological and psychosocial management. Lancet Neurol
9(1):77–93. doi:10.1016/s1474-4422(09)70271-6
4. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe
L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro
F, Tomezsko J, Constantin C (2010) Diagnosis and management
of Duchenne muscular dystrophy, part 2: implementation of
multidisciplinary care. Lancet Neurol 9(2):177–189. doi:10.1016/
s1474-4422(09)70272-8
5. National Institute for Health and Care Excellence (2011) Final
accreditation report: ‘diagnosis and management of Duchenne
muscular dystrophy’ guideline. http://www.nice.org.uk/Media/
Default/About/accreditation/accreditation-decisions/Duchenne-
Muscular-Dystrophy-Care-Considerations-Working-Group-final-
decision.pdf. Accessed 22 Sept 2014
6. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R,
Bushby K (2002) Survival in Duchenne muscular dystrophy:
improvements in life expectancy since 1967 and the impact
of home nocturnal ventilation. Neuromuscul Disord 12(10):
926–929. doi:10.1016/S0960-8966(02)00140-2
7. Eagle M, Bourke J, Bullock R, Gibson M, Mehta J, Giddings D,
Straub V, Bushby K (2007) Managing Duchenne muscular
dystrophy—the additive effect of spinal surgery and home noc-
turnal ventilation in improving survival. Neuromuscul Disord
17(6):470–475. doi:10.1016/j.nmd.2007.03.002
8. Wagner KR, Lechtzin N, Judge DP (2007) Current treatment of
adult Duchenne muscular dystrophy. Biochim Biophys Acta
1772(2):229–237. doi:10.1016/j.bbadis.2006.06.009
9. Beresford B, Stuttard L (2014) Young adults as users of adult
healthcare: experiences of young adults with complex or life-
limiting conditions. Clin Med 14(4):404–408. doi:10.7861/clin
medicine.14-4-404
10. Kirk S (2008) Transitions in the lives of young people with
complex healthcare needs. Child Care Health Dev 34(5):
567–575. doi:10.1111/j.1365-2214.2008.00862.x
11. Rahbek J, Werge B, Madsen A, Marquardt J, Steffensen BF,
Jeppesen J (2005) Adult life with Duchenne muscular dystrophy:
observations among an emerging and unforeseen patient popu-
lation. Pediatr Rehabil 8(1):17–28
12. Schrans DGM, Abbott D, Peay HL, Pangalila RF, Vroom E,
Goemans N, Vles JSH, Aldenkamp AP, Hendriksen JGM (2013)
Transition in Duchenne muscular dystrophy: an expert meeting
report and description of transition needs in an emergent patient
population: (parent project muscular dystrophy transition expert
meeting 17–18 June 2011, Amsterdam, The Netherlands). Neu-
romuscul Disord 23(3):283–286. doi:10.1016/j.nmd.2012.08.009
13. All Party Parliamentary Group for Muscular Dystrophy (2009)
Access to specialist neuromuscular care: The Walton report.
http://www.muscular-dystrophy.org/assets/0000/9943/Walton_
report.pdf. Accessed 22 Sept 2014
14. CARE-NMD project CARE-NMD website. http://www.care-
nmd.eu/. Accessed 22 Sept 2014
15. Bladen CL, Rafferty K, Straub V, Monges S, Moresco A, Dawkins
H, Roy A, Chamova T, Guergueltcheva V, Korngut L, Campbell
C, Dai Y, Barisic N, Kos T, Brabec P, Rahbek J, Lahdetie J,
Tuffery-Giraud S, Claustres M, Leturcq F, Ben Yaou R, Walter
MC, Schreiber O, Karcagi V, Herczegfalvi A, Viswanathan V, de
la Caridad Guerrero Sarmiento I, Ambrosini A, Ceradini F,
Kimura E, van den Bergen JC, Rodrigues M, Roxburgh R, Lus-
akowska A, Oliveira J, Santos R, Neagu E, Butoianu N, Artemieva
S, Rasic VM, Posada M, Palau F, Lindvall B, Bloetzer C, Kar-
aduman A, Topaloglu H, Inal S, Oflazer P, Stringer A, Shatillo
AV, Martin AS, Peay H, Flanigan KM, Salgado D, von Rekowski
B, Lynn S, Heslop E, Gainotti S, Taruscio D, Kirschner J, Ver-
schuuren J, Bushby K, Beroud C, Lochmuller H (2013) The
TREAT-NMD Duchenne muscular dystrophy registries: concep-
tion, design, and utilization by industry and academia. Hum Mutat
34(11):1449–1457. doi:10.1002/humu.22390
16. Abbott D (2012) Other voices, other rooms: reflections on talking
to young men with Duchenne muscular dystrophy and their
families about transition to adulthood. Child Soc 26(3):241–250.
doi:10.1111/j.1099-0860.2012.00437.x
17. Muscular Dystrophy Campaign (2008) Building on the founda-
tions: focus on physio. http://www.muscular-dystrophy.org/
assets/0000/6276/Access_to_physio_report.pdf. Accessed 22
Sept 2014
18. Hill ME, Phillips MF (2006) Service provision for adults with
long-term disability: a review of services for adults with chronic
neuromuscular conditions in the United Kingdom. Neuromuscul
Disord 16(2):107–112
19. Abbott D, Carpenter J (2014) ‘Wasting precious time’: young
men with Duchenne muscular dystrophy negotiate the transition
to adulthood. Disabil Soc 29(8):1192–1205. doi:10.1080/
09687599.2014.916607
20. Abbott D, Carpenter J, Bushby K (2012) Transition to adulthood
for young men with Duchenne muscular dystrophy: research from
the UK. Neuromuscul Disord 22(5):445–446. doi:10.1016/j.nmd.
2012.02.004
21. Crowley R, Wolfe I, Lock K, McKee M (2011) Improving the
transition between paediatric and adult healthcare: a systematic
review. Arch Dis Child. doi:10.1136/adc.2010.202473
640 J Neurol (2015) 262:629–641
123
22. Pellegrini N, Guillon B, Prigent H, Pellegrini M, Orlikovski D,
Raphael J-C, Lofaso F (2004) Optimization of power wheelchair
control for patients with severe Duchenne muscular dystrophy.
Neuromuscul Disord 14(5):297–300. doi:10.1016/j.nmd.2004.02.
005
23. Purdy S (2010) Avoiding hospital admissions. What does the
research evidence say. The King’s Fund, London
24. Purdy S, Paranjothy S, Huntley A, Thomas R, Mann M, Huws D,
Brindle P, Elwyn G (2012) Interventions to reduce unplanned
hospital admission: a series of systematic reviews. National
Institute for Health Research, Bristol
25. Muscular Dystrophy Campaign (2011) Invest to save: improving
services and reducing costs. http://www.muscular-dystrophy.org/
assets/0002/4945/Muscular_Dystrophy_Campaign_Invest_to_
Save_Report.pdf. Accessed 22 Sept 2014
26. Jaffer F, Reilly MM, Quinlivan R, Muntoni F, Turner C, Parton
M, Lunn M, Hilton-Jones D, Korkodilos M, Hanna MG (2013)
Emergency neuromuscular admissions are avoidable: a regional
audit of unplanned hospital admissions of neuromuscular patients
2009–2011: final results and recommendations. J Neurol Neuro-
surg Psychiatry 84(11):e2. doi:10.1136/jnnp-2013-306573.7
27. Korkodilos M, Hajioff S, Gardner C, Overett S, Ibrahim S, Jaffer
F, Hanna MG (2012) Audit of unplanned admissions in neuro-
muscular patients: a collaborative audit. NHS Audit, Information
and Analysis Unit, London
28. Lannon CM, Peterson LE (2013) Pediatric collaborative networks
for quality improvement and research. Acad Pediatr 13(6, Sup-
plement):S69–S74. doi:10.1016/j.acap.2013.07.004
29. Mogayzel PJ, Dunitz J, Marrow LC, Hazle LA (2014) Improving
chronic care delivery and outcomes: the impact of the cystic
fibrosis care center network. BMJ Qual Saf 23(Suppl 1):i3–i8.
doi:10.1136/bmjqs-2013-002363
30. Evangelista T, van Engelen B, Bushby K (2014) 200th ENMC
international workshop ‘‘European reference networks: recom-
mendations and criteria in the neuromuscular field’’, 18–20
October 2013, Naarden, The Netherlands. Neuromuscul Disord
24(6):537–545
31. NHS England (2013) D04/S/a 2013/14 NHS standard contract for
neurosciences: specialised neurology (adult). Schedule 2A—ser-
vice specifications
J Neurol (2015) 262:629–641 641
123
